In vivo investigation of the efficacy of a customized solution to attenuate injury following low-flow ischemia and reperfusion injury in the jejunum of horses

American Journal of Veterinary Research

Volumn 65, Issue 4, 2004, Pages 485-490

  Van Hoogmoed, Linda M ^a   Nieto, Jorge E ^a   Spier, Sharon J ^a   Snyder, Jack R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ALBUMIN; ALLOPURINOL; DEFEROXAMINE; DIMETHYL SULFOXIDE; ELECTROLYTE; GLUCOSE; GLUTAMINE; GUAIFENESIN; KETAMINE; LIDOCAINE; PROSTAGLANDIN E1; RINGER LACTATE SOLUTION; XYLAZINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENUATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG SOLUTION; HISTOPATHOLOGY; HORSE; IN VIVO STUDY; INCISION; INTESTINE BIOPSY; INTESTINE BLOOD FLOW; INTESTINE FLUID; INTESTINE INJURY; INTESTINE ISCHEMIA; INTESTINE MUCOSA PERMEABILITY; INTESTINE VILLUS; JEJUNUM; MECHANICAL PROBE; MESENTERIC ARTERY; MESENTERIC VEIN; NONHUMAN; REPERFUSION INJURY;

ALBUMINS; ANALYSIS OF VARIANCE; ANIMALS; BIOPSY; HISTOLOGICAL TECHNIQUES; HORSES; JEJUNUM; PHARMACEUTICAL SOLUTIONS; REPERFUSION INJURY;

ANIMALIA; EQUIDAE; EQUUS CABALLUS;

EID: 1842588674     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2004.65.485     Document Type: Article

References (37)

1. de Oca J, Cuadrado S, Vallet J, et al. Protective effects of Lazaroid U74389G on intestinal graft after heterotopic small bowel transplantation in rats. J Surg Res 1998;75:18-23.
2. Moore RM, Muir WW, Granger DN. Mechanisms of gastrointestinal ischemia-reperfusion injury and potential therapeutic interventions: A review and its implications in the horse. J Vet Intern Med 1995;9:115-132.
3. White NA, Moore JN, Trim CM. Mucosal alterations in experimentally induced small intestinal strangulation obstruction in ponies. Am J Vet Res 1980;41:193-198.
4. Arden WA, Slocombe RF, Stick JA, et al. Morphologic and ultrastructural evaluation of effect of ischemia and dimethyl sulfoxide on equine jejunum. Am J Vet Res 1990;51:1784-1791.
5. Freeman DE, Cimprich RE, Richardson DW, et al. Early mucosal healing and chronic changes in pony jejunum after various types of strangulation obstruction. Am J Vet Res 1988;49:810-818.
6. Van Hoogmoed LM, Snyder JR, Nieto JG, et al. Effect of a leukocyte-depleting filter in an extracorporeal circuit used for low-flow ischemia and reperfusion injury in the equine jejunum. Am J Vet Res 2001;62:87-96.
7. Dabareiner RM, Snyder JR, White NA, et al. Microvascular permeability and endothelial cell morphology associated with low flow ischemia/reperfusion injury in the equine jejunum. Am J Vet Res 1995;56:639-648.
8. Vatistas NJ, Snyder JR, Hildebrand SV, et al. Effects of U-74389G, a novel 21-aminosteroid, on small intestinal ischemia and reperfusion injury in horses. Am J Vet Res 1996;57:762-770.
9. Johnston JK, Freeman DE, Gillette D, et al. Effects of superoxide dismutase on injury induced by anoxia and reoxygenation in equine small intestine in vitro. Am J Vet Res 1991;52:2050-2054.
10. Van Hoogmoed LM, Snyder JR, Nieto J, et al. In vitro evaluation of a customized solution for use in attenuating effects of ischemia and reperfusion in the equine small intestine. Am J Vet Res 2001; 62:1679-1686.
11. Van Hoogmoed LM, Nieto JE, Snyder JR, et al. In vitro evaluation of an intraluminal solution to attenuate effects of ischemia and reperfusion in the small intestine in the small intestine of horses. Am J Vet Res 2002;63:1389-1394.
12. Chiu CJ, McArdle AH, Brown R, et al. Intestinal mucosal lesion in low flow states. A morphological, hemodynamic, and metabolic reappraisal. Arch Surg 1970;101:478-483.
13. Van Hoogmoed LM, Snyder JR, Nieto JE, et al. Use of an extracorporeal circuit to evaluate effects of ischemia and reperfusion of the equine large colon. Am J Vet Res 2000;61:1042-1051.
14. Moore RM. Clinical relevance of intestinal reperfusion injury in horses. J Am Vet Med Assoc 1997;211:1362-1366.
15. Dabareiner RM, Sullins KE, White NA, et al. Serosal injury in the equine jejunum and ascending colon after ischemia reperfusion or intraluminal distention and decompression. Vet Surg 2001;30:114-125.
16. Blikslager AT, Roberts MC. Mechanisms of intestinal mucosal repair. J Am Vet Med Assoc 1997;211:1437-1441.
17. Flaherty JT, Weisfeldt ML. Reperfusion injury. Free Radic Biol Med 1988;5:409-419.
18. Hernandez LA, Grisham MB, Granger DN. A role for iron in oxidant mediated ischemic injury to intestinal microvasculature. Am J Physiol 1987;253:G49-G53.
19. Zimmerman BJ, Grisham MB, Granger DN. Role of oxidants in ischemia/reperfusion-induced granulocyte infiltration. Am J Physiol 1990;258:G185-G190.
20. Southard JH, Rice MJ, Belzer FO. Preservation of renal function by adenosine-stimulated ATP synthesis in hypothermically perfused dog kidneys. Cryobiology 1985;22:237-242.
21. Massberg S, Messmer K. The nature of ischemia/reperfusion injury. Transplantation 1998;30:4217-4223.
22. Windmueller HG. Glucose utilization in the small intestine. Adv Enzymol Relat Areas Mol Biol 1982;53:201-237.
23. Souba WW, Smith RJ, Wilmore DW. Glutamine metabolism by the intestinal tract. JPEN J Parenter Enteral Nutr 1985;9:608-617.
24. Zhang W, Frankel WL, Bain A, et al. Glutamine reduces bacterial translocation after small bowel transplantation in cyclosporine-treated rats. J Surg Res 1995;58:159-164.
25. Zhang W, Frankel WL, Singh A, et al. Improvement of structure and function in orthotopic small bowel transplantation in the rat by glutamine. Transplantation 1993;56:512-517.
26. Sasaki K, Park JO, Bain A, et al. Glutamine protects function and improves preservation of small bowel segments. J Surg Res 1997; 73:90-94.
27. Zhang W, Bain A, Rombeau JL. Insulin-like growth factor-I (IGF-I) and glutamine improve structure and function in the small bowel allograft. J Surg Res 1995;59:6-12.
28. Ko TC, Beaucamp RD, Townsend M, et al. Glutamine is essential for epidermal growth factor-stimulated intestinal cell proliferation. Surgery 1993;114:147-154.
29. Nilsson UA, Schoenberg MH, Aneman A, et al. Free radicals and pathogenesis during ischemia and reperfusion of the cat small intestine. Gastroenterology 1994;106:629-636.
30. Ricardo SD, Bertram JF, Ryan GB. Podocyte architecture in puromycin aminonucleoside-treated rats administered tungsten or allopurinol. Exp Nephrol 1995;3:270-279.
31. Kurose I, Granger DN. Evidence implicating xanthine oxidase and neutrophils in reperfusion-induced microvascular dysfunction. Ann N Y Acad Sci 1994;723:158-179.
32. Long WA, Rubin LJ. Prostacyclin and PGE1 treatment of pulmonary hypertension. Am Rev Respir Dis 1987;136:733-766.
33. Kunkel SL, Remick DG, Spengler M, et al. Modulation of macrophage-derived interleukin-1 and tumor necrosis factor by prostaglandin E2. Adv Prostaglandin Thromboxane Leukot Res 1987;17:155-158.
34. Fantone JC, Kunkel SL, Ward PA, et al. Suppression by prostaglandin E1 of vascular permeability induced vasoactive inflammatory mediators. J Immunol 1980;125:2591-2596.
35. Shinohara H, Tanaka A, Fujimoto T, et al. Prostaglandin E1 resuscitates hepatic organic anion transport independent of hemodynamic effect after warm ischemia. J Surg Res 1997;68:56-62.
36. 1 reduces injury in hepatic allografts following preservation. J Surg Res 1991;50:595-601.
37. Gerard MP, Blikslager AT, Roberts MC, et al. The characteristics of intestinal injury peripheral to strangulating obstruction lesions in the equine small intestine. Equine Vet J 1999;31:331-335.